Gefitinib
Gefitinib (originally coded ZD1839) is a drug used in the treatment of certain types of cancer. Acting in a similar manner to erlotinib (marketed as Tarceva), gefitinib selectively targets the mutant proteins in malignant cells. It is marketed by AstraZeneca under the trade name Iressa.
| Catalog Number | PIPE-0769 |
| Alternative Name(s) | Iressa ZD1839 Irressat |
| Research Area | Natural Extract |
| Molecular Formula | C22H24ClFN4O3 |
| CAS# | 184475-35-2 |
| SMILES | COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4 |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/gefitinib-item-9708.html |